Ubicación del inventario

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Sujeto a disponibilidad

Documentation

Descargar MSDS

Descargar COA de muestra

Incluye: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, potencia, informe de elucidación estructural (SER) y datos analíticos adicionales según el producto.

N-Nitroso of N-Demethyl Erythromycin A

● En Stock

Número de catálogo:	VE007865
N.º CAS:	N/A
Fórmula mol.::	C36H64N2O14
Peso mol.::	748.90 g/mol

Solicitar cotización

Añadir a la lista de RFQ

Información adicional sobre el N-Nitroso of N-Demethyl Erythromycin A

Fármaco de origen

Azithromycin / Erythromycin

Nombre IUPAC

N-((2S, 3S, 4S, 6S)-2-(((3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-14-ethyl-7, 12, 13-trihydroxy-4-(((4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3, 5, 7, 9, 11, 13-hexamethyl-2, 10-dioxooxacyclotetradecan-6-yl)oxy)-3-hydroxy-6-methyltetrahydro-2H-pyran-4-yl)-N-methylnitrous amide

Sinónimos farmacopeicos

N/A

Otros sinónimos

N/A

SMILES

O=NN([C@@H]1[C@H](O)[C@H](O[C@@H]([C@](C)(O)C[C@H]2C)[C@@H](C)[C@H](OC3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C2=O)=O)O[C@@H](C)C1)C

InChI

InChI=1S/C36H64N2O14/c1-13-24-36(10,45)29(41)19(4)26(39)17(2)15-34(8,44)31(52-33-27(40)23(38(11)37-46)14-18(3)48-33)20(5)28(21(6)32(43)50-24)51-25-16-35(9,47-12)30(42)22(7)49-25/h17-25,27-31,33,40-42,44-45H,13-16H2,1-12H3/t17-,18+,19+,20+,21-,22+,23+,24-,25?,27+,28+,29-,30+,31-,33+,34-,35-,36-/m1/s1

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Datos adicionales de caracterización

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Descripción

N-Nitroso of N-Demethyl Erythromycin A (Azithromycin) is an N-nitroso derivative of the secondary amine present in Azithromycin | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Azithromycin production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.